TARA
Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4
Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss…
Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss…